Nashai researches, develops and procures novel ingredients to be converted into dietary supplements, over-the-counter medicines and active pharmaceutical ingredients. Currently, Nashai is introducing an all-natural tea extract product that is enriched with theaflavin. The trade name is Teaflavin®. Teaflavin®, a combination of theaflavin from black tea and catechins from green tea, is clinically proven (as published in The Archives of Internal Medicine) to act as a lipid-lowering agent (LDL cholesterol) in people suffering from mild to moderately high cholesterol. At the same time, we have patented theaflavin for its cholesterol lowering effect.

Teaflavin® is a nutraceutical combining thousands of years of Chinese medical wisdom pertaining to the benefits of green and black tea with western clinical methodologies, allowing Teaflavin® to claim a depth of review only matched by pharmaceutical grade products. Theaflavin and catechin, the prominent compounds in Teaflavin®, are known for preventive applications and health maintenance: cholesterol reduction, colon health, cardiovascular health, heart disease prevention, immune support, anti-oxidants, and weight-loss.

Nashai Biotech LLC is a multi-national company registered and headquartered in Nashville, Tennessee, USA with branch offices located in Irvine, California and Shanghai, China.

Our goal is to introduce intellectual property for science-based products that enhance healthcare by targeting high-impact disease states. A main component of our current focus is scientific analysis and assessment of traditional plant extracts for marketing on a global basis.

Read more about Nashai or for more information, please contact us.